Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity

by Tang, Derek, Colayco, Danielle, Piercy, James, Patel, Vaishali, Globe, Denise, Chancellor, Michael
Published 2014

Efficacy and Safety of OnabotulinumtoxinA in Treating Neurogenic Detrusor Overactivity: A Systematic Review and Meta-analysis

by Xin Zhou, Hui-Lei Yan, Yuan-Shan Cui, Huan-Tao Zong, Yong Zhang
Published 2015-01-01

Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis

by Hejia Yuan, Yuanshan Cui, Jitao Wu, Peng Peng, Xujie Sun, Zhenli Gao
Published 2017-03-01

Efficacy and Safety of OnabotulinumtoxinA in Patients With Neurogenic Detrusor Overactivity Caused by Spinal Cord Injury: A Systematic Review and Meta-analysis

by Guang-Ping Li, Xiao-Yan Wang, Yong Zhang
Published 2018-12-01

Managing Urological Disorders in Multiple Sclerosis Patients: A Review of Available and Emerging Therapies

by Riccardo Bientinesi, Carlo Gandi, PierFrancesco Bassi
Published 2020-06-01

A Urodynamic Comparison of Neural Targets for Transcutaneous Electrical Stimulation to Acutely Suppress Detrusor Contractions Following Spinal Cord Injury

by Sean Doherty, Sean Doherty, Anne Vanhoestenberghe, Lynsey Duffell, Rizwan Hamid, Sarah Knight
Published 2019-12-01

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction

by Hann-Chorng Kuo
Published 2020-06-01

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis

by Shang-Jun Wu, Yu-Qiong Xu, Zheng-Yan Gao, Zhi-Peng Wang, Feng Zhao, Lin Liu, Sheng Wang
Published 2019-01-01

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder

by Qin-Qin Gong, Yu-Qiong Xu, Jun Xu, Xiao-Yan Ding, Chong Guo, Chong Guo
Published 2020-01-01

Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?

by Amélie Huynh Le Maux, Bernadette Pignol, Delphine Behr-Roussel, Jean-Luc Blachon, Pierre-Etienne Chabrier, Sandrine Compagnie, Philippe Picaut, Jacques Bernabé, François Giuliano, Pierre Denys
Published 2015-12-01

Long-term Outcome of Infants with Spina Bifida Through Assessment of the Prognostic Value of Hostile Bladder Parameters

by Ali Tekin, Sibel Tiryaki, Ezgi Altun Tanıl, İbrahim Ulman
Published 2021-06-01

In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections

by Banakhar M, Yamani A
Published 2021-09-01

The use of botulinum toxin for the treatment of overactive bladder syndrome

by Bogdan Orasanu, Sangeeta T Mahajan
Published 2013-01-01

Prediction of autonomic dysreflexia during urodynamics: a prospective cohort study

by Matthias Walter, Stephanie C. Knüpfer, Jacquelyn J. Cragg, Lorenz Leitner, Marc P. Schneider, Ulrich Mehnert, Andrei V. Krassioukov, Martin Schubert, Armin Curt, Thomas M. Kessler
Published 2018-04-01

Hyperactive bladder: concept of disease and paradigms in the treatment

by G. G. Krivoborodov, E. I. Tur, D. A. Shirin
Published 2021-04-01

Trigonal-Sparing vs. Trigonal-Involved OnabotulinumtoxinA Injection for the Treatment of Overactive Bladder: A Systematic Review and Meta-Analysis

by Yuanshan Cui, Yuanshan Cui, Tong Cai, Tiantian Dong, Xiaoyi Zhang, Zhongbao Zhou, Youyi Lu, Yong Zhang, Jitao Wu, Zhenli Gao, Yongqiang Wang, Liying Dong
Published 2021-10-01

Spinal cord stimulation for the restoration of bladder function after spinal cord injury

by Casey J. Steadman, Warren M. Grill
Published 2020-05-01